Clemence Ligneul1
1Nuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom
Synopsis
This course aims at introducing diffusion-weighted magnetic resonance spectroscopy (DW MRS) to people with a basic understanding of diffusion MRI. Hopefully, you will be able to seize whether DW MRS techniques can be useful for your research question, and to get an idea of its implementation, from acquisition to analysis.
Take-home
- Grasping
the potential of DW-MRS for your research question.
- Including
DW-MRS in your study: practical considerations.
- References
and resources for setting up.Resonate at various frequencies and gain specificity!
Diffusion-weighted
MRI techniques, based on water diffusion, are very potent and sensitive to
microstructure. However, water ubiquity can be sometimes a source of confusion.
Disentangling intracellular, extracellular, neuronal, glial contributions from
the diffusion signal in the brain can be tricky when modelling the
microstructure.
Diffusion-weighted
magnetic resonance spectroscopy (DW-MRS) relies on the diffusion properties of
concentrated metabolites. The most reported are N-Acetylaspartate (NAA),
choline compounds (tCho) and creatine/phosphocreatine (tCr). Other J-coupled or
less concentrated metabolites, such as glutamate (Glu), myo-inositol (Ins),
taurine (Tau), lactate (Lac), glutamine (Gln) etc are exploitable when the
spectral resolution and the sensitivity keep up. Coming from the cellular
metabolism, these molecules are mostly intracellular and some of them are even
more specific to neurons (typically NAA) or astrocytes (typically Ins) (Fig.1).
Therefore, their diffusion properties directly reflect specific cell morphology
and other cell properties! Then, why aren’t we all diffusion spectroscopists? There
is no magic tool: the more concentrated metabolites are about 10-4 less
concentrated than water in the brain, and therefore the lack of sensitivity is
a major limitation (for now) when the regions of interest are small.
Nonetheless,
various DW-MRS methods have been successfully implemented in clinical and
preclinical systems. Exploring a large range of diffusion times (0.4 ms with
OGSE to 2000 ms with PGSTE1,2) or harnessing high diffusion weightings (b=60 μm2/ms)3, with simple or double diffusion encoding4, these methods (Fig.2) explore a broad range of questions. From the quest of biomarkers in pathologies (notably being sensitive to astrocytic or glial activation5,6, with typical cell morphology evaluated by modeling, as in Fig.3) to
biophysics queries (cytosolic viscosity, intracellular microscopic
anisotropy, metabolite compartmentation), DW-MRS is ripe for the picking. Methods: the case of upfield 1H DW-MRS in the brain [7]
The
single voxel approach
The low
metabolites concentration and the signal loss inherent to diffusion methods
impose a relatively large single voxel in most studies. In rodents, typical
voxel sizes encompass a full structure (e.g. the whole striatum, hippocampus
etc), particularly when the studies take advantage of the strong gradient
systems of preclinical systems. In humans at high fields, voxels can reach few cm3 [2]. A pure temporal FID is acquired from the top of the echo (no k-space
sampling).
A few
words on metabolites properties
Relaxation8
Metabolites
have longer transversal relaxation times than water (typically 100-300ms at 11.7T).
When a localization sequence is coupled to diffusion gradients, echo times can
be quite long, particularly on clinical settings (100-150ms): some signal remains
thanks to their relatively long T2. Longitudinal relaxation times are about 1.5s
with extremes for the tCr peak at 4ppm (1s) and for Taurine (>2s). Macromolecules
are another important contributor to spectra, particularly at short TE (T2,MM ~ 20-30ms)
Diffusivity3,9
Metabolites
diffusivity is about an order of magnitude lower than water diffusivity. The
apparent diffusion coefficient of metabolites in brain tissue for intermediary
diffusion times is about 0.1-0.2 μm2/ms. Macromolecules have a very low
diffusivity (~0.01 μm2/ms).
Processing
the data
The result
of an acquisition is a very crowded 1D-spectrum (FT of the acquired FID). Not
only metabolites and macromolecules are overlapping, but the spectrum appearance depends strongly on the sequence, and therefore tools for robust
quantification are recommended (LCModel, jMRUI, TARQUIN among others). The
basis set of metabolites used for fitting should be quantum mechanically simulated.
Empiric macromolecular baseline should be included in the basis set. Before quantification,
it is crucial to correct the phase and frequency of each repetition in order to
coherently add the signal and avoid an artificial signal loss10,
particularly at higher diffusion-weightings.
Modeling
the data
The diffusion
data from different metabolites can be primarily modeled with infinite cylinders
models, as it has been shown that metabolite diffusion primarily occurs in long
fibers11. At long diffusion times, the
cell complexity (size, embranchments) induces an ADC time dependence reflected
by a morphometric modeling2,6.
Beware
of motion artifacts
Motion
during acquisition: on preclinical systems, the minimum care consists in an
efficient holding system: bit and ear bars make a big difference. Without them,
an increase of metabolite ADC of 50-100% can be easily observed (when the
signal is still quantifiable).Acknowledgements
No acknowledgement found.References
[1] Ligneul et al., ISMRM 2017
[2] Palombo et al., 2016, 10.1073/pnas.1504327113
[3] Ligneul et al., 2017, DOI 10.1002/mrm.26217
[4] Shemesh et al., 2014, DOI 10.1038/ncomms5958
[5] Ercan et al., 2015, DOI 10.1093/brain/aww031
[6] Ligneul et al, 2019, DOI 0.1016/j.neuroimage.2019.02.046
[7] Ronen et Valette, 2015, DOI
10.1002/9780470034590.emrstm1471
[8] De Graaf et al., 2006, DOI 10.1002/mrm.20946
[9] Pfeuffer et al., 2000, DOI 10.1097/00004647-200004000-00011
[10] Upadhyay et al. 2007, DOI 10.1002/mrm.21372
[11] Najac et al. 2016, https://doi.org/10.1007/s00429-014-0968-5